Evidence map›Paper›PMID 15077193›Full record

ArticleOncogene2004

Overexpression of FAK promotes Ras activity through the formation of a FAK/p120RasGAP complex in malignant astrocytoma cells.

Timothy P Hecker, Qiang Ding, Tanya A Rege, Steven K Hanks, Candece L Gladson

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Frontiers in pharmacology · 2017
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Timothy P HeckerDepartment of Pathology, Division of Neuropathology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Qiang Ding
Tanya A Rege
Steven K Hanks
Candece L Gladson
University of Alabama at Birmingham · USBirmingham VA Medical Center · USVanderbilt University · US

Funding

CARP, A Novel Cell Death RegulatorR01CA097100 · NCI · UNIVERSITY OF PENNSYLVANIA · PI EL-DEIRY, WAFIK S · 2002 to 2006
$1.6M
VITRONECTIN IN THE MALIGNANCY OF GLIOBLASTOMAR01CA059958 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GLADSON, CANDECE L · 1994 to 2003
$866k
NCI NIH HHS CA59958NCI NIH HHS CA97100NIGMS NIH HHS GM49882
6 · The paper itself

Abstract

Focal adhesion kinase (FAK) signaling may be mediated through the modulation of Ras activity. We have shown previously that grade III malignant astrocytoma biopsy samples exhibit elevated levels of FAK, and that overexpression of FAK in U-251MG malignant astrocytoma cells promotes the phosphorylation of Shc, a potential upstream mediator of Ras activity. Here, we report that overexpression of FAK promotes Ras activity in U-251MG malignant astrocytoma cells cultured in aggregate suspension or as monolayers adherent to vitronectin. The overexpression of FAK also promoted the association of FAK with p120RasGAP, which is a negative regulator of Ras activity, in the U-251MG cells cultured in aggregate suspension, with this association being abrogated upon plating of the cells onto vitronectin. An association of FAK with p120RasGAP also was observed in malignant astrocytoma biopsy samples, but not in normal brain samples. As overexpression of FAK in U-251MG cells in aggregate suspension culture reduced the amount of p120RasGAP complexed with active Ras, we hypothesize that the association of FAK with p120 RasGAP may facilitate Ras activity. The overexpression of a mutated FAK in which the Y397 had been mutated to F did not result in the formation of the FAK/p120RasGAP complex and did not promote Ras activity, indicating that the Y397 residue of FAK plays a role in the formation of this complex and in the activation of Ras. Moreover, the overexpression of mutated FAK (397F) was found to inhibit anchorage-independent growth. These data provide the basis for a previously undescribed mechanism in which the elevated expression of FAK can promote Ras activity through its competitive recruitment of p120RasGAP, thereby diminishing the association of p120RasGAP with active Ras.

Indexed as

AnimalsAstrocytomaCell DivisionFocal Adhesion Kinase 1Focal Adhesion Protein-Tyrosine KinasesGuanosine TriphosphateHumansp120 GTPase Activating ProteinProtein-Tyrosine Kinasesras ProteinsRatsFocal Adhesion Kinase 1Focal Adhesion Protein-Tyrosine KinasesGuanosine Triphosphatep120 GTPase Activating ProteinProtein-Tyrosine KinasesPTK2 protein, humanPtk2 protein, ratras Proteins

Identifiers

PMID15077193
OpenAlexW2025890181

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.